ProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Free Report)’s share price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.00 and traded as high as $0.0110. ProtoKinetix shares last traded at $0.0110, with a volume of 1,000 shares traded.
ProtoKinetix Trading Up 5,400.0%
About ProtoKinetix
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc and changed its name to ProtoKinetix, Incorporated in July 2003.
Featured Stories
- Five stocks we like better than ProtoKinetix
- 3 AI Infrastructure Stocks to Watch Beyond NVIDIA
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
Receive News & Ratings for ProtoKinetix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProtoKinetix and related companies with MarketBeat.com's FREE daily email newsletter.
